WELL TOLERATED ORAL COMBINATION OF CHLORAMBUCIL (LEUKERAN), METHOTREXATE, FLUOROURACIL, PREDNISONE (LMFP) IN DISSEMINATED BREAST-CANCER

被引:8
作者
MAYR, AC
JUNGI, WF
SENN, HJ
机构
关键词
D O I
10.1016/S0305-7372(79)80025-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:115 / 120
页数:6
相关论文
共 13 条
[1]  
ANSFIELD FJ, 1969, CANCER RES, V29, P1062
[2]   RESPONSE AND SURVIVAL IN ADVANCED BREAST-CANCER AFTER 2 NON-CROSS-RESISTANT COMBINATIONS [J].
BRAMBILLA, C ;
DELENA, M ;
ROSSI, A ;
VALAGUSSA, P ;
BONADONNA, G .
BRITISH MEDICAL JOURNAL, 1976, 1 (6013) :801-804
[3]  
BRUNNER KW, 1975, CANCER-AM CANCER SOC, V36, P1208, DOI 10.1002/1097-0142(197510)36:4<1208::AID-CNCR2820360405>3.0.CO
[4]  
2-0
[5]  
CARTER SK, 1972, CANCER-AM CANCER SOC, V30, P1543, DOI 10.1002/1097-0142(197212)30:6<1543::AID-CNCR2820300621>3.0.CO
[6]  
2-V
[7]  
HOOGSTRATEN B, 1976, CANCER, V38, P13, DOI 10.1002/1097-0142(197607)38:1<13::AID-CNCR2820380104>3.0.CO
[8]  
2-5
[9]  
KHUNG CL, 1966, CLIN PHARMACOL THER, V7, P527
[10]  
MOORE GE, 1968, CANCER CHEMOTH REP, V52, P661